FRANKLIN RESOURCES INC - DECIPHERA PHARMACEUTICALS IN ownership

DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 144 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
FRANKLIN RESOURCES INC ownership history of DECIPHERA PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2023$154,064
-8.9%
10,942
-0.1%
0.00%
Q1 2023$169,208
-5.6%
10,952
+0.1%
0.00%
Q4 2022$179,339
+45.8%
10,942
-17.8%
0.00%
Q1 2022$123,000
-99.9%
13,317
-99.6%
0.00%
-100.0%
Q3 2021$108,595,000
-2.9%
3,195,854
+4.6%
0.04%
-4.7%
Q2 2021$111,888,000
-35.0%
3,056,213
-20.4%
0.04%
-38.6%
Q1 2021$172,219,000
-15.9%
3,840,734
+7.1%
0.07%
-19.5%
Q4 2020$204,701,000
+18.0%
3,586,839
+6.0%
0.09%
+3.6%
Q3 2020$173,525,000
-1.0%
3,382,551
-4.2%
0.08%
-6.7%
Q2 2020$175,339,000
+31.6%
3,531,488
+9.1%
0.09%
+1.1%
Q1 2020$133,283,000
-9.7%
3,237,383
+36.4%
0.09%
+14.1%
Q4 2019$147,678,000
+437.1%
2,372,722
+192.9%
0.08%
+420.0%
Q3 2019$27,493,000
+385.1%
810,060
+224.0%
0.02%
+400.0%
Q4 2017$5,668,000
+19.4%
250,0000.0%0.00%
+50.0%
Q3 2017$4,748,000250,0000.00%
Other shareholders
DECIPHERA PHARMACEUTICALS IN shareholders Q4 2021
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 1,209,571$72,236,00020.73%
SV Health Investors, LLC 449,951$26,871,00018.64%
Redmile Group, LLC 4,978,941$297,342,0005.49%
Sunesis Advisors, LLC 96,299$5,751,0005.29%
Eversept Partners, LP 418,652$25,001,8973.43%
Opaleye Management Inc. 222,000$13,081,0002.64%
Avoro Capital Advisors LLC 1,860,000$111,079,0002.20%
SPHERA FUNDS MANAGEMENT LTD. 282,965$16,899,0001.59%
SECTORAL ASSET MANAGEMENT INC 224,359$13,399,0001.23%
Artal Group S.A. 650,000$38,818,0001.09%
View complete list of DECIPHERA PHARMACEUTICALS IN shareholders